BMI View: Mauritius’ pharmaceutical and healthcare markets will continue to expand over the forecast
period, albeit from a small market base. Rising demand for healthcare due to an ageing population, as well
as high spending per capita, economic growth and political stability, will all contribute to driving the
development of these markets at a significant pace. However, despite a continued rise in Mauritius’ drug
exports, the negative pharmaceutical trade balance will grow over the next years, given rising demand for
health and the limited drug manufacturing capacity.
Headline Expenditure Projections
Pharmaceuticals: MUR6.17bn (USD176mn) in 2015 to MUR6.60bn (USD184mn) in 2016; +7.0% in local
currency terms and +4.7% in US dollar terms. Forecast in line with last quarter.
Healthcare: MUR19.73bn (USD562mn) in 2015 to MUR20.76bn (USD578mn) in 2016; +5.2% growth in
local currency terms, and +2.9% in US dollar terms. Forecast in line with last quarter.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Mauritius 2014-2020) 7
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mauritius 2012-2020) 12
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mauritius 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mauritius 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mauritius 2012-2020) 17
Industry Risk Reward Index 18
Middle East and Africa Risk/Reward Index - Q2 2016 18
Mauritius Risk Reward Index 25
Regulatory Review 27
Intellectual Property Issues 27
Pricing Regime 27
Reimbursement Regime 31
Market Overview 32
Healthcare Sector 33
Research & Development 33
Clinical Trials 33
Epidemiology 33
Competitive Landscape 35
Research-Based Industry 35
Table: Multinational Market Activity 37
Demographic Forecast 38
Table: Population Headline Indicators (Mauritius 1990-2025) 39
Table: Key Population Ratios (Mauritius 1990-2025) 39
Table: Urban/Rural Population & Life Expectancy (Mauritius 1990-2025) 40
Table: Population By Age Group (Mauritius 1990-2025) 40
Table: Population By Age Group % (Mauritius 1990-2025) 41
Glossary 43
Methodology 45
Pharmaceutical Expenditure Forecast Model 45
Healthcare Expenditure Forecast Model 45
Notes On Methodology 46
Risk/Reward Index Methodology 47
Index Overview 48
Table: Pharmaceutical Risk/Reward Index Indicators 48
Indicator Weightings 49

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Mauritius 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mauritius 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mauritius 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mauritius 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mauritius 2012-2020)
Table: Multinational Market Activity
Table: Population Headline Indicators (Mauritius 1990-2025)
Table: Key Population Ratios (Mauritius 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Mauritius 1990-2025)
Table: Population By Age Group (Mauritius 1990-2025)
Table: Population By Age Group % (Mauritius 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators